Search company, investor...

EffRx

effrx.com

Founded Year

2012

Stage

Acquired | Acquired

Total Raised

$10.25M

About EffRx

EffRx operates as a commercial-stage pharmaceutical company that develops and commercializes drugs. Its product range includes buffered soluble alendronate used in the treatment of osteoporosis. The company was founded in 2012 and is based in Freienbach, Switzerland. In May 2023, EffRx was acquired by Abiogen Pharma. The terms of the transaction were not disclosed.

Headquarters Location

Wolleraustrasse 41B

Freienbach, 8807,

Switzerland

+41 44 503 78 60

Missing: EffRx's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: EffRx's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing EffRx

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

EffRx is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

EffRx Patents

EffRx has filed 3 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/5/2011

3/14/2017

Excipients, Conditions of the mucous membranes, Oral mucosal pathology, Salivary gland pathology, Dosage forms

Grant

Application Date

12/5/2011

Grant Date

3/14/2017

Title

Related Topics

Excipients, Conditions of the mucous membranes, Oral mucosal pathology, Salivary gland pathology, Dosage forms

Status

Grant

Latest EffRx News

Abiogen Pharma acquires majority stake in EffRx

Jun 2, 2023

Abiogen, a pharmaceutical firm based in the Italian city of Pisa, has acquired a 97.09 percent stake in EffRx Pharmaceuticals. Since 2014, Abioge...

EffRx Frequently Asked Questions (FAQ)

  • When was EffRx founded?

    EffRx was founded in 2012.

  • Where is EffRx's headquarters?

    EffRx's headquarters is located at Wolleraustrasse 41B, Freienbach.

  • What is EffRx's latest funding round?

    EffRx's latest funding round is Acquired.

  • How much did EffRx raise?

    EffRx raised a total of $10.25M.

  • Who are the investors of EffRx?

    Investors of EffRx include Abiogen, Sobera Capital and Seventh Framework Programme.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.